“The Global Pancreatic Cancer Therapeutics Market will Grow to USD 4,390.04 Million by 2026, at a CAGR of 9.93%
”
FEATURED COMPANIES
- Amgen Inc.
- Celgene Corporation
- ERYtech Pharma
- Genentech, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
The Global Pancreatic Cancer Therapeutics Market size was estimated at USD 2,487.48 Million in 2020 and expected to reach USD 2,726.08 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.93% to reach USD 4,390.04 Million by 2026.
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
This research report categorizes the Pancreatic Cancer Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pancreatic Cancer Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pancreatic Cancer Therapeutics Market, including Amgen Inc., Apexigen Inc, AstraZeneca PLC, Boston Scientific Corporation, Canon Medical Systems Corporation, Celgene Corporation, Clovis Oncology, Eli Lilly and Company, ERYtech Pharma, F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, Galera Therapeutics Inc, Genentech, Inc., GlaxoSmithKline Plc, Immunovia AB, Merck & Co., Inc., Myriad Genetics Inc., Novartis International AG, Pfizer, Inc., PharmaCyte Biotech Inc., Propanc Biopharma, Inc., Rafael Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., and Threshold Pharmaceutical.
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
1. What is the market size and forecast of the Global Pancreatic Cancer Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pancreatic Cancer Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pancreatic Cancer Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Pancreatic Cancer Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Pancreatic Cancer Therapeutics Market?
6. What is the market share of the leading vendors in the Global Pancreatic Cancer Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Pancreatic Cancer Therapeutics Market?
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pancreatic Cancer Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the Pancreatic Cancer Therapeutics Market was studied across Chemotherapy and Targeted Therapy.
- Based on Type, the Pancreatic Cancer Therapeutics Market was studied across Endocrine Pancreatic Cancer and Exocrine Pancreatic cancer.
- Based on Region, the Pancreatic Cancer Therapeutics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pancreatic Cancer Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pancreatic Cancer Therapeutics Market, including Amgen Inc., Apexigen Inc, AstraZeneca PLC, Boston Scientific Corporation, Canon Medical Systems Corporation, Celgene Corporation, Clovis Oncology, Eli Lilly and Company, ERYtech Pharma, F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, Galera Therapeutics Inc, Genentech, Inc., GlaxoSmithKline Plc, Immunovia AB, Merck & Co., Inc., Myriad Genetics Inc., Novartis International AG, Pfizer, Inc., PharmaCyte Biotech Inc., Propanc Biopharma, Inc., Rafael Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., and Threshold Pharmaceutical.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pancreatic Cancer Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pancreatic Cancer Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pancreatic Cancer Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Pancreatic Cancer Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Pancreatic Cancer Therapeutics Market?
6. What is the market share of the leading vendors in the Global Pancreatic Cancer Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Pancreatic Cancer Therapeutics Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Amgen Inc.
- Celgene Corporation
- ERYtech Pharma
- Genentech, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Type Outlook
3.5. Region Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in cases of patients suffering with pancreatic cancer
5.1.1.2. Growth in prevalence of obesity, alcohol consumption, & smoking
5.1.1.3. Increasing health expenditures for pancreatic drugs
5.1.1.4. Growth in number of new therapies introduced in the market
5.1.2. Restraints
5.1.2.1. Possible side effects associated with therapeutics
5.1.3. Opportunities
5.1.3.1. Dedicated R&D efforts and clinical trials by pharma companies
5.1.3.2. Advancements in diagnostic technology and molecular biology
5.1.3.3. Adoption of combination therapies
5.1.4. Challenges
5.1.4.1. Lack of screening techniques in very earliest stage
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Pancreatic Cancer Therapeutics Market, by Product
6.1. Introduction
6.2. Chemotherapy
6.3. Targeted Therapy
7. Pancreatic Cancer Therapeutics Market, by Type
7.1. Introduction
7.2. Endocrine Pancreatic Cancer
7.3. Exocrine Pancreatic cancer
8. Americas Pancreatic Cancer Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pancreatic Cancer Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand
10. Europe, Middle East & Africa Pancreatic Cancer Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Amgen Inc.
12.2. Apexigen Inc
12.3. AstraZeneca PLC
12.4. Boston Scientific Corporation
12.5. Canon Medical Systems Corporation
12.6. Celgene Corporation
12.7. Clovis Oncology
12.8. Eli Lilly and Company
12.9. ERYtech Pharma
12.10. F. Hoffmann-La Roche AG
12.11. FUJIFILM Holdings Corporation
12.12. Galera Therapeutics Inc
12.13. Genentech, Inc.
12.14. GlaxoSmithKline Plc
12.15. Immunovia AB
12.16. Merck & Co., Inc.
12.17. Myriad Genetics Inc.
12.18. Novartis International AG
12.19. Pfizer, Inc.
12.20. PharmaCyte Biotech Inc.
12.21. Propanc Biopharma, Inc.
12.22. Rafael Pharmaceuticals
12.23. Shire Plc
12.24. Teva Pharmaceutical Industries Ltd.
12.25. Threshold Pharmaceutical
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 16. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2026
FIGURE 18. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 23. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 24. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 11. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 12. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SCORES
TABLE 40. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: RANKING
TABLE 43. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 44. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: LICENSE & PRICING
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Type Outlook
3.5. Region Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in cases of patients suffering with pancreatic cancer
5.1.1.2. Growth in prevalence of obesity, alcohol consumption, & smoking
5.1.1.3. Increasing health expenditures for pancreatic drugs
5.1.1.4. Growth in number of new therapies introduced in the market
5.1.2. Restraints
5.1.2.1. Possible side effects associated with therapeutics
5.1.3. Opportunities
5.1.3.1. Dedicated R&D efforts and clinical trials by pharma companies
5.1.3.2. Advancements in diagnostic technology and molecular biology
5.1.3.3. Adoption of combination therapies
5.1.4. Challenges
5.1.4.1. Lack of screening techniques in very earliest stage
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Pancreatic Cancer Therapeutics Market, by Product
6.1. Introduction
6.2. Chemotherapy
6.3. Targeted Therapy
7. Pancreatic Cancer Therapeutics Market, by Type
7.1. Introduction
7.2. Endocrine Pancreatic Cancer
7.3. Exocrine Pancreatic cancer
8. Americas Pancreatic Cancer Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pancreatic Cancer Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand
10. Europe, Middle East & Africa Pancreatic Cancer Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Amgen Inc.
12.2. Apexigen Inc
12.3. AstraZeneca PLC
12.4. Boston Scientific Corporation
12.5. Canon Medical Systems Corporation
12.6. Celgene Corporation
12.7. Clovis Oncology
12.8. Eli Lilly and Company
12.9. ERYtech Pharma
12.10. F. Hoffmann-La Roche AG
12.11. FUJIFILM Holdings Corporation
12.12. Galera Therapeutics Inc
12.13. Genentech, Inc.
12.14. GlaxoSmithKline Plc
12.15. Immunovia AB
12.16. Merck & Co., Inc.
12.17. Myriad Genetics Inc.
12.18. Novartis International AG
12.19. Pfizer, Inc.
12.20. PharmaCyte Biotech Inc.
12.21. Propanc Biopharma, Inc.
12.22. Rafael Pharmaceuticals
12.23. Shire Plc
12.24. Teva Pharmaceutical Industries Ltd.
12.25. Threshold Pharmaceutical
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 16. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2026
FIGURE 18. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 23. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 24. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY ENDOCRINE PANCREATIC CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, BY EXOCRINE PANCREATIC CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 11. ARGENTINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 12. BRAZIL PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 13. CANADA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 14. MEXICO PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. ASIA-PACIFIC PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. AUSTRALIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. CHINA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. INDIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. INDONESIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. JAPAN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. MALAYSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. PHILIPPINES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. SINGAPORE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. SOUTH KOREA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. THAILAND PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. FRANCE PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. GERMANY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ITALY PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. NETHERLANDS PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. QATAR PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. RUSSIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. SAUDI ARABIA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SOUTH AFRICA PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SPAIN PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. UNITED ARAB EMIRATES PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. UNITED KINGDOM PANCREATIC CANCER THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SCORES
TABLE 40. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: RANKING
TABLE 43. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 44. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 45. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 46. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 47. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 48. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 49. GLOBAL PANCREATIC CANCER THERAPEUTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
- Amgen Inc.
- Apexigen Inc
- AstraZeneca PLC
- Boston Scientific Corporation
- Canon Medical Systems Corporation
- Celgene Corporation
- Clovis Oncology
- Eli Lilly and Company
- ERYtech Pharma
- F. Hoffmann-La Roche AG
- FUJIFILM Holdings Corporation
- Galera Therapeutics Inc
- Genentech, Inc.
- GlaxoSmithKline Plc
- Immunovia AB
- Merck & Co., Inc.
- Myriad Genetics Inc.
- Novartis International AG
- Pfizer, Inc.
- PharmaCyte Biotech Inc.
- Propanc Biopharma, Inc.
- Rafael Pharmaceuticals
- Shire Plc
- Teva Pharmaceutical Industries Ltd.
- Threshold Pharmaceutical
Note: Product cover images may vary from those shown
LOADING...
